Depression in Alzheimer's disease: Consequence or contributing factor?

Expert Review of Neurotherapeutics

Volumn 11, Issue 11, 2011, Pages 1501-1503

  Mintzer, Jacobo ^a   O'Neill, Courtney ^b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Alzheimer's disease; cognitive impairment; dementia; depression

Indexed keywords

ALZHEIMER DISEASE; BRAIN DAMAGE; COGNITIVE DEFECT; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; PSEUDODEMENTIA; REVIEW; RISK FACTOR;

ALZHEIMER DISEASE; DEPRESSION; HUMANS;

EID: 80054944109     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.145     Document Type: Review

References (11)

1. Kral VA, Emery OB. Long-term follow-up of depressive pseudodementia of the aged. Can. J Psychiatry 34, 445-446 (1989)
2. Sheline YI. Depression and the hippocampus: cause or effect? Biol. Psychiatry 70, 308-309 (2011)
3. Steffens DC, Payne ME, Greenberg DL et al. Hippocampal volume and incident dementia in geriatric depression. Am. J Geriatr. Psychiatry 10, 62-71 (2002)
4. Parmelee PA, Katz IR, Lawton MP. Incidence of depression in long-term care settings. J Gerontol. 47, M189-M196 (1992)
5. Olin JT, Schneider LS, Katz IS et al. National Institute of Mental Health -provisional diagnostic criteria for depression of Alzheimer disease. Am. J Ger. Psychiatry 10, 125-128 (2002)
6. Olin JT, Schneider LS, Katz IR et al. Provisional diagnostic criteria for depression of Alzheimer disease. Am. J Geriatr. Psychiatry 10, 125-128 (2002)
7. Lyketsos CG, Baker L, Warren A et al. Major and minor depression in Alzheimer's disease: prevalence and impact. J Neuropsychiatry Clin. Neurosciences 9, 556-561 (1997)
8. Lyketsos CG, Sheppard JME, Steele CS et al. A randomized, placebo-controlled, double-blind, clinical trial of sertraline in the treatment of depression complicating Alzheimer disease: initial results from the Depression in Alzheimer Disease Study (DIADS). Am. J Psychiatry 157, 1686-1689 (2000)
9. Drye LT, Martin BK, Frangakis CE et al. Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)? Int. J Geriatr. Psychiatry 26, 573-583 (2011)
10. Weintraub D, Rosenberg PB, Drye LT et al. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. Am. J Geriatr. Psychiatry 18, 332-340 (2010)
11. Rosenberg PB, Drye LT, Martin BK et al. Sertraline for the treatment of depression in Alzheimer disease. Am. J Geriatr. Psychiatry 18, 136-145 (2010)